Literature DB >> 8860990

Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation.

H Nagase1, K Suzuki, Y Itoh, C C Kan, M R Gehring, W Huang, K Brew.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8860990     DOI： 10.1007/978-1-4613-0335-0_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

Review 1.  Computational sequence analysis of the tissue inhibitor of metalloproteinase family.

Authors:  D A Douglas; Y E Shi; Q A Sang
Journal:  J Protein Chem       Date:  1997-05

2.  Intravitreous injection of a membrane depolarization agent causes retinal degeneration via matrix metalloproteinase-9.

Authors:  Raghuveer S Mali; Mei Cheng; Shravan K Chintala
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-06       Impact factor: 4.799

3.  Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community.

Authors:  Ravi Dhingra; Michael J Pencina; Peter Schrader; Thomas J Wang; Daniel Levy; Karol Pencina; Deborah A Siwik; Wilson S Colucci; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

4.  Lymphangiogenesis and lymphatic remodeling induced by filarial parasites: implications for pathogenesis.

Authors:  Sasisekhar Bennuru; Thomas B Nutman
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

Review 5.  Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?

Authors:  Marzena Wyganowska-Świątkowska; Maja Matthews-Kozanecka; Teresa Matthews-Brzozowska; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Int J Mol Sci       Date:  2018-01-15       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.